3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
21
Lymphoma, Non-Hodgkin
14
Leukemia, Myeloid, Acute
14
Leukemia, Lymphocytic, Chronic, B-Cell
11
Congenital Abnormalities
11
Myelodysplastic Syndromes
10
Lymphoma, Mantle-Cell
9
Hodgkin Disease
9
Multiple Myeloma
8
Lymphoma, Large B-Cell, Diffuse
8
Lymphoma
8
Leukemia
8
Lymphoma, Follicular
7
Lymphoma, B-Cell, Marginal Zone
7
Waldenstrom Macroglobulinemia
6
Leukemia, Myeloid, Accelerated Phase
6
Sezary Syndrome
5
Recurrence
5
Myeloproliferative Disorders
5
Mycosis Fungoides
5
Lymphoma, T-Cell, Cutaneous
5
Lymphoma, Large-Cell, Immunoblastic
5
Graft vs Host Disease
5
Burkitt Lymphoma
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, Extranodal NK-T-Cell
4
Leukemia, Myelomonocytic, Chronic
4
Leukemia, Myeloid, Chronic-Phase
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Lymphoma, T-Cell, Peripheral
3
Interventions
blinatumomab
16
Cyclophosphamide
15
fludarabine phosphate
8
fludarabine
8
Methotrexate
7
Cytarabine
7
Rituximab
6
Vincristine
5
Mercaptopurine
5
Melphalan
4
Daunorubicin
4
obinutuzumab
3
Whole-Body Irradiation
3
Immunotherapy, Adoptive
3
Granulocyte Colony-Stimulating Factor
3
Etoposide
3
Doxorubicin
3
Dexamethasone
3
Asparaginase
3
tisagenlecleucel
2
thymoglobulin
2
pegaspargase
2
Vindesine
2
Thioguanine
2
Teniposide
2
Stem Cell Transplantation
2
Radiotherapy
2
Prednisone
2
Prednisolone
2
N,N-dicyclohexyl-isoborneol-10-sulfonamide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasm, Residual
×
Transplantation
×
Lymphoid
×
Clear all
NCT07443592
2026-03-02
LAL-2025
PETHEMA Foundation
Phase NA
Not yet recruiting
330 enrolled